These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Cellular Models for the Serpinopathies. Fra A, D'Acunto E, Laffranchi M, Miranda E. Methods Mol Biol; 2018; 1826():109-121. PubMed ID: 30194596 [Abstract] [Full Text] [Related]
26. The selective advantage of alpha1-antitrypsin deficiency. Lomas DA. Am J Respir Crit Care Med; 2006 May 15; 173(10):1072-7. PubMed ID: 16439713 [Abstract] [Full Text] [Related]
32. Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency. Lomas DA. COPD; 2013 Mar 15; 10 Suppl 1():17-25. PubMed ID: 23527623 [Abstract] [Full Text] [Related]
35. Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. Lomas DA, Mahadeva R. J Clin Invest; 2002 Dec 15; 110(11):1585-90. PubMed ID: 12464660 [No Abstract] [Full Text] [Related]
40. Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates. Mallya M, Phillips RL, Saldanha SA, Gooptu B, Brown SC, Termine DJ, Shirvani AM, Wu Y, Sifers RN, Abagyan R, Lomas DA. J Med Chem; 2007 Nov 01; 50(22):5357-63. PubMed ID: 17918823 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]